戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ion and psychosis with the use of divalproex sodium (valproate).
2 development of the child exposed in utero to sodium valproate.
3 e concentrations of the HDACIs vorinostat or sodium valproate.
4  and carbamazepine and greater than those of sodium valproate.
5 tivators in common clinical use--lithium and sodium valproate.
6 ncy over older AEDs namely carbamazepine and sodium valproate.
7 orarginine and histone deacetylase inhibitor sodium valproate.
8 , and typically responsive to treatment with sodium valproate.
9 whether single or multiple administration of sodium valproate, a GABA agonist, would prevent the expr
10                 Some mood stabilizers, e.g., sodium valproate and carbamazepine, are human teratogens
11 ood stabilizers (lithium, carbamazepine, and sodium valproate) and plasma levels of these drugs to fu
12                                              Sodium valproate, benzodiazepines and topiramate were re
13                                              Sodium valproate has been a first-line antiepileptic dru
14             Prescribing of carbamazepine and sodium valproate have declined since 1994 despite being
15 avioural difficulties in children exposed to sodium valproate in utero.
16 gnancy registers has not only confirmed that sodium valproate is teratogenic but also that it may be
17 tising neurologists had long suspected--that sodium valproate is the most effective drug in the treat
18 dividuals; and Group V, 7 patients receiving sodium valproate monotherapy.
19 is undoubtedly a phamacogenetic component to sodium valproate's teratogenic and neurodevelopmental ef
20 disorders in children exposed to monotherapy sodium valproate (VPA) (6/50, 12.0%; aOR 6.05, 95%CI 1.6
21 etiracetam (LEV) 1.00 (0.16 to 1.84) p=0.02; sodium valproate (VPA) 0.74 (0.10 to 1.38) p=0.02; topir
22                                              Sodium valproate (VPA) administered to neonatal mice cau
23                                              Sodium valproate (VPA) is widely used throughout the wor
24           One proposed adjunctive therapy is sodium valproate (VPA), an anticonvulsant known to promo
25    Therefore, we have examined the effect of sodium valproate, which enhances GABA function, on the d

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。